Characteristics of Cardiac Abnormalities in Pediatric Patients With Acute COVID-19
- PMID: 37065296
- PMCID: PMC10097430
- DOI: 10.7759/cureus.36093
Characteristics of Cardiac Abnormalities in Pediatric Patients With Acute COVID-19
Abstract
Introduction Coronavirus disease 2019 (COVID-19) is known to cause cardiac abnormalities in adults. Cardiac abnormalities are well-described in multisystem inflammatory syndrome in children, but effects in children with acute COVID-19 are less understood. In this multicenter study, we assessed the cardiac effects of acute COVID-19 among hospitalized children (<21 years) admitted to three large healthcare systems in New York City. Methods We performed a retrospective observational study. We examined electrocardiograms, echocardiograms, troponin, or B-type natriuretic peptides. Results Of 317 admitted patients, 131 (41%) underwent cardiac testing with 56 (43%) demonstrating cardiac abnormalities. Electrocardiogram abnormalities were the most common (46/117 patients (39%)), including repolarization abnormalities and QT prolongation. Elevated troponin occurred in 14/77 (18%) patients and B-type natriuretic peptide in 8/39 (21%) patients. Ventricular dysfunction was identified in 5/27 (19%) patients with an echocardiogram, all of whom had elevated troponin. Ventricular dysfunction resolved by first outpatient follow-up. Conclusion Electrocardiogram and troponin can assist clinicians in identifying children at risk for cardiac injury in acute COVID-19.
Keywords: covid-19; electrocardiogram; myocarditis; pediatrics; ventricular dysfunction.
Copyright © 2023, Pasternack et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.Clin Pediatr (Phila). 2021 Feb;60(2):119-126. doi: 10.1177/0009922820961771. Epub 2020 Sep 25. Clin Pediatr (Phila). 2021. PMID: 32975439
-
Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19.Int J Cardiol Heart Vasc. 2021 Feb;32:100719. doi: 10.1016/j.ijcha.2021.100719. Epub 2021 Jan 25. Int J Cardiol Heart Vasc. 2021. PMID: 33521240 Free PMC article.
-
Describing our experience with the effects of multisystem inflammatory syndrome in children with COVID-19 on the cardiovascular system.Cardiol Young. 2023 Nov;33(11):2312-2314. doi: 10.1017/S1047951123000173. Epub 2023 Feb 1. Cardiol Young. 2023. PMID: 36720714
-
Cardiac Effects of COVID-19 Infection, MIS-C, and the Vaccine in Infants and Children: What Is Known and Future Implications.Am J Perinatol. 2022 Dec;39(S 01):S1-S6. doi: 10.1055/s-0042-1757238. Epub 2022 Oct 28. Am J Perinatol. 2022. PMID: 36307093 Review.
-
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review.Curr Heart Fail Rep. 2021 Jun;18(3):163-168. doi: 10.1007/s11897-021-00505-2. Epub 2021 Mar 5. Curr Heart Fail Rep. 2021. PMID: 33666855 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources